Unexpectedly, no significant difference of above examined parameters between these groups was observed, except the non-COPD controls showing better pulmonary functions, less abundant ASM mass, and NOX4 and TGF-β proteins, as compared with all COPD groups (Table 2). This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.